METHENAMINE Drug Patent Profile
✉ Email this page to a colleague
When do Methenamine patents expire, and what generic alternatives are available?
Methenamine is a drug marketed by Aurobindo Pharma Ltd, Impax Labs Inc, Ingenus Pharms Llc, Jubilant Cadista, Micro Labs, and Zydus Lifesciences. and is included in six NDAs.
The generic ingredient in METHENAMINE is methenamine hippurate. There are ten drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the methenamine hippurate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Methenamine
A generic version of METHENAMINE was approved as methenamine hippurate by AUROBINDO PHARMA LTD on July 5th, 2016.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for METHENAMINE?
- What are the global sales for METHENAMINE?
- What is Average Wholesale Price for METHENAMINE?
Summary for METHENAMINE
| US Patents: | 0 |
| Applicants: | 6 |
| NDAs: | 6 |
| Drug Prices: | Drug price information for METHENAMINE |
| DailyMed Link: | METHENAMINE at DailyMed |
US Patents and Regulatory Information for METHENAMINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma Ltd | METHENAMINE HIPPURATE | methenamine hippurate | TABLET;ORAL | 205661-001 | Jul 5, 2016 | AB | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Jubilant Cadista | METHENAMINE HIPPURATE | methenamine hippurate | TABLET;ORAL | 217675-001 | Dec 1, 2023 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Impax Labs Inc | METHENAMINE HIPPURATE | methenamine hippurate | TABLET;ORAL | 076411-001 | Jun 20, 2003 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
